Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod

OBJECTIVE: Lymphopenia is a common occurrence of disease-modifying therapies (DMTs) for relapsing-remitting MS (RRMS). The aim of this study was to dissect the prevalence of various lymphocyte subsets in patients with RRMS treated with 2 DMTs commonly associated with lymphopenia, dimethyl fumarate (...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakhaei-Nejad, Maryam, Barilla, David, Lee, Chieh-Hsin, Blevins, Gregg, Giuliani, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746425/
https://www.ncbi.nlm.nih.gov/pubmed/29296636
http://dx.doi.org/10.1212/NXI.0000000000000432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746425/
https://www.ncbi.nlm.nih.gov/pubmed/29296636
http://dx.doi.org/10.1212/NXI.0000000000000432

Ejemplares similares